Transverse myelitis is a rare inflammatory condition in which the immune system damages the spinal cord, causing sudden weakness, numbness, and bladder or bowel problems below the level of the injury. It strikes roughly one to eight people per million each year, and while about a third recover well, another third are left with serious, lasting disability. The condition is not a single disease so much as a pattern of spinal cord inflammation that can be triggered by infections, autoimmune disorders, or sometimes nothing identifiable at all.
What Happens in the Spinal Cord
The hallmark of transverse myelitis is inflammation that stretches across the width of the spinal cord at one or more levels. That inflammation damages myelin, the insulating sheath around nerve fibers, and can also injure the nerve fibers themselves. The result is a communication breakdown between the brain and everything below the affected segment.1PubMed Central. Transverse myelitis Research has shown that a signaling molecule called IL-6 plays a central role. In laboratory and animal studies, IL-6 was both necessary and sufficient to cause spinal cord cell injury by ramping up damaging inflammatory pathways.2JCI Insight. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis This helps explain why the damage tends to be concentrated in specific spinal cord segments rather than spread evenly.
Symptoms and How They Develop
Transverse myelitis usually comes on over hours to a few days, though some people develop symptoms over one to two weeks. The classic triad is weakness in the legs (or sometimes all four limbs if the neck-level cord is involved), altered sensation from a certain point downward, and bladder and bowel dysfunction.3PubMed. Proposed diagnostic criteria and nosology of acute transverse myelitis Many people describe a band-like tightness around the torso at the level of the lesion, sometimes called the “MS hug” even in cases unrelated to multiple sclerosis.
Sensory symptoms vary widely. Some people lose the ability to feel light touch or temperature below a certain dermatome; others develop burning, stabbing neuropathic pain that can become one of the most difficult long-term problems. Neuropathic pain after transverse myelitis sometimes resists standard painkillers and anti-seizure medications. In severe refractory cases, implanted drug pumps delivering medication directly to the spinal fluid have been used successfully when oral drugs, nerve blocks, and even acupuncture fell short.4PubMed Central. Effective management of intractable neuropathic pain using an intrathecal morphine pump in a patient with acute transverse myelitis
Bladder problems deserve special mention because they affect daily life enormously yet often get less attention than limb weakness. Urinary retention is common in the acute phase, and many people are left with some degree of neurogenic bladder long term, requiring intermittent catheterization or medication to manage urgency and incomplete emptying.
Known Triggers and Causes
Roughly half of transverse myelitis cases follow a respiratory or gastrointestinal infection within the preceding one to four weeks. The leading theory is molecular mimicry: the immune system mounts a response against the infection but mistakenly attacks spinal cord tissue that shares surface features with the pathogen.5PubMed Central. Guillain-Barré syndrome, transverse myelitis and infectious diseases Individual host factors clearly play a role too, because millions of people get the same infections without developing spinal cord inflammation.
In other cases, transverse myelitis turns out to be the first visible sign of a broader autoimmune condition. Two antibody-mediated diseases have reshaped how neurologists think about the condition:
- AQP4-positive NMOSD: Antibodies against the water channel protein aquaporin-4 cause attacks of myelitis and optic neuritis. MRI features that suggest this diagnosis include lesions stretching across three or more vertebral segments, involvement of the junction between the brainstem and upper spinal cord, and so-called “bright spotty lesions” on T2 imaging.6American Journal of Neuroradiology. MRI Features of Aquaporin-4 Antibody–Positive Longitudinally Extensive Transverse Myelitis: Insights into the Diagnosis of Neuromyelitis Optica Spectrum Disorders
- MOG antibody disease: Antibodies targeting myelin oligodendrocyte glycoprotein produce attacks that can look similar on the surface. In a study of 54 patients with MOG-antibody myelitis, isolated transverse myelitis was the first symptom in over half. MRI patterns that pointed toward MOG rather than AQP4 included damage confined to gray matter, seen as a characteristic “H sign” on cross-sectional images, and a lack of contrast enhancement. About 59% of MOG patients relapsed within a median follow-up of two years, most often with optic neuritis.7JAMA Neurology. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody
Distinguishing between these causes matters because the treatments are different and the risk of future attacks varies considerably. A sizable number of cases remain truly “idiopathic,” meaning no underlying cause is ever found despite thorough testing.
When Transverse Myelitis Is Really Early Multiple Sclerosis
One of the most anxiety-provoking questions for someone diagnosed with transverse myelitis is whether it will turn out to be the first attack of multiple sclerosis. The answer depends largely on whether the inflammation involves the entire width of the cord or only part of it. When only part of the cord cross-section is inflamed, called acute partial transverse myelitis, the risk of converting to MS is substantially higher. In one study of 73 patients with partial myelitis, roughly 44% went on to develop MS, while about 48% stayed as a one-time event.8PubMed. Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis Factors that raised the risk included lesions on brain MRI, oligoclonal bands in the spinal fluid, a family history of MS, and worse disability at the first attack.
For people who meet strict criteria for full-width idiopathic transverse myelitis, the conversion rate is lower. A large series found that about 13% converted to MS after a median follow-up of nearly three years.9PubMed Central. Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series So the risk is real but considerably smaller. Neurologists often recommend a baseline brain MRI and spinal fluid analysis specifically to stratify this risk, even when the spinal cord is the only symptomatic site.
Getting the Diagnosis Right
Transverse myelitis is a clinical diagnosis supported by MRI and lumbar puncture, but making it accurately requires ruling out conditions that look almost identical. Spinal cord infarction, essentially a stroke of the spinal cord, is the great mimic. It causes sudden weakness and sensory loss in a pattern that overlaps heavily with inflammatory myelitis. The key difference is speed: spinal cord infarction typically reaches its worst point within six hours, while transverse myelitis usually worsens over days.10PubMed Central. Spinal Cord Infarction Versus Idiopathic Transverse Myelitis: Clinical, Radiological, and Functional Insights From a Retrospective Cohort Study On MRI, infarction tends to produce thin, linear lesions, whereas transverse myelitis creates patchier, more swollen-looking ones.
The initial MRI can sometimes be normal in spinal cord infarction, which is why repeat imaging is recommended if the clinical picture does not fit neatly with transverse myelitis. In one reported case, a repeat MRI revealed vertebral body involvement pointing to an interrupted blood supply, a finding not seen in inflammatory myelitis.11PubMed Central. Spinal Cord Infarction Mimicking Acute Transverse Myelitis Compression from tumors, abscesses, or herniated discs must also be excluded, which is why an urgent MRI of the full spine is standard when someone presents with rapidly progressive weakness and sensory changes.
Once compression and vascular causes are excluded, contrast-enhanced MRI becomes especially important for distinguishing among inflammatory causes. A study comparing diagnostic accuracy with and without gadolinium contrast found that raters correctly classified the cause of long spinal cord lesions about 84 to 88% of the time using post-contrast images, compared with only about 54 to 60% with standard T2-weighted images alone.12PubMed Central. Utility of MRI Enhancement Pattern in Myelopathies With Longitudinally Extensive T2 Lesions Specific enhancement patterns, such as ring enhancement or cloud-like enhancement, can point toward particular diagnoses like neuromyelitis optica or sarcoidosis.
Acute Treatment
The first-line treatment for transverse myelitis is high-dose intravenous corticosteroids, typically methylprednisolone given over three to five days. The goal is to tamp down the immune attack as quickly as possible. In a pilot study of children with severe acute myelitis, the methylprednisolone group walked independently at a median of 23 days compared with 97 days in a historical comparison group, and 80% achieved full recovery within a year versus just 10% without the treatment.13PubMed Central. High dose methylprednisolone in severe acute transverse myelopathy These results, though from a small study, reflect the general clinical experience that early steroid treatment improves outcomes.
When someone does not respond to steroids within about 24 to 48 hours, or continues to worsen, the next step is therapeutic plasma exchange. This procedure filters the blood to remove the antibodies and inflammatory molecules that are driving the attack. Guidelines from the American Society for Apheresis list plasma exchange as second-line therapy for myelitis based on accumulated clinical experience and case series.14PubMed Central. Early Therapeutic Plasma Exchange in Pediatric Transverse Myelitis: A Case Report and Scoping Review Some neurologists now advocate starting plasma exchange earlier, especially in cases that look severe from the outset, rather than waiting for steroid failure.
In a subset of children with longitudinally extensive myelitis treated with methylprednisolone, about 41% achieved complete recovery while the remainder showed partial recovery.15PubMed Central. Role of Methyl Prednisolone in Longitudinal Extensive Transverse Myelitis (LETM) in Children These numbers underscore that even with prompt treatment, transverse myelitis often leaves residual deficits that require ongoing management.
Long-Term Prevention When a Cause Is Found
For people whose transverse myelitis turns out to be part of an antibody-mediated disease like AQP4-positive NMOSD, long-term immunosuppressive therapy is critical to prevent relapses that could cause cumulative spinal cord damage. Several drugs targeting specific immune pathways have been tested in clinical trials for AQP4-positive NMOSD and are now approved in many countries. Similar trials are underway for MOG antibody disease.16Taylor & Francis Online / Expert Review of Neurotherapeutics. Current perspectives on the diagnosis and management of acute transverse myelitis
For idiopathic transverse myelitis with no identified underlying condition, the evidence for long-term immunosuppression is much thinner. Most of these cases remain monophasic, meaning the attack happens once and does not recur. The challenge is that some fraction of “idiopathic” cases will later reveal themselves as an early manifestation of MS, NMOSD, or MOG antibody disease, which is why follow-up blood work and repeat imaging are usually recommended over the first year or two.
What Recovery Looks Like
Recovery from transverse myelitis follows a rough rule of thirds: about one-third of patients recover well with little lasting disability, one-third end up with moderate permanent problems, and the remaining third remain severely disabled. Recovery usually begins within one to three months and can continue for up to two years, though the fastest improvement typically happens in the first three to six months.17PubMed Central. Transverse Myelitis
Children tend to fare better than adults. About half of pediatric patients make a complete recovery within two years.18PubMed. Pediatric transverse myelitis Why children recover more fully is not entirely clear, though greater neural plasticity in the developing nervous system likely plays a role. Severity at the worst point of the attack is one of the best early predictors: someone who can still move their legs somewhat during the acute phase has much better odds of walking independently later than someone who becomes completely paralyzed.
Rehabilitation Approaches
Because the spinal cord damage in transverse myelitis often leaves lasting weakness, spasticity, or sensory loss, rehabilitation is a major part of recovery. Standard physical therapy for myelitis includes resistance exercises, stretching and splinting for tight muscles, and functional training to relearn transfers and walking. In one pediatric case, a structured program of resistance exercises, soft tissue work, and splinting brought a child from significant spasticity to full bilateral muscle strength within 23 days of therapy, along with near-complete functional independence.19PubMed Central. Physiotherapy management of acute transverse myelitis in a pediatric patient in a Nigerian hospital: a case report
Newer techniques are expanding the rehab toolbox. Blood flow restriction training, which uses cuffs to partially restrict blood flow to a limb during low-load exercises, may help build strength in people who cannot tolerate heavy resistance training because of neurological weakness.20PubMed. Use of blood flow restriction and electrical stimulation in a patient with transverse myelitis: a case report Electrical nerve stimulation applied to weakened muscles has also shown promise. In one case involving overlap between transverse myelitis and Guillain-Barré syndrome, direct transcutaneous electrical nerve stimulation of peripheral nerves improved the therapeutic effect of other treatments by a reported 89.5%, with reductions in neuropathic pain, motor deficits, and bladder dysfunction.21PubMed Central. Functional Recovery and Regenerative Effects of Direct Transcutaneous Electrical Nerve Stimulation in Treatment of Post-COVID-19 Guillain-Barré and Acute Transverse Myelitis Overlap Syndrome: A Clinical Case These results come from individual case reports rather than large trials, so they should be taken as encouraging signals rather than definitive evidence.
The Vaccine Question
Transverse myelitis has occasionally been reported after vaccination, and this is an area where misinformation runs ahead of the data. Case reports linking various vaccines to transverse myelitis date back decades, with temporal associations ranging from several days to three months.22PubMed. Transverse myelitis and vaccines: a multi-analysis The critical question is whether vaccines actually increase the risk or whether these are coincidences in a condition that has a background rate.
A large case-centered analysis following nearly 64 million vaccine doses found only seven cases of transverse myelitis in the primary risk window of 5 to 28 days after vaccination. Statistically, there was no significant increase in risk.23PubMed Central. Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis During the COVID-19 pandemic, however, a pharmacovigilance study using the World Health Organization’s adverse event database found a statistically significant association between SARS-CoV-2 vaccines (both mRNA and viral-vector types) and reports of transverse myelitis.24PubMed Central. Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization’s Database
These two findings are not as contradictory as they sound. The pre-COVID study examined routine childhood and adult vaccines and found no signal. The COVID-vaccine study used spontaneous reports to a safety-monitoring database, which can detect signals but cannot establish incidence rates or prove causation. Both research teams acknowledged that even if the association is real, the absolute risk is extremely small compared with the neurological risks posed by the infections the vaccines prevent. The honest read of the evidence is that vaccination is a plausible but very rare trigger, and that the risk-benefit calculation still favors immunization for the vast majority of people.
Mental Health After Transverse Myelitis
The psychological toll of transverse myelitis deserves more attention than it usually gets. In a study comparing psychiatric symptoms in people with transverse myelitis versus stroke, 70% of the myelitis patients scored above the threshold for significant psychological distress. Nearly a third met criteria for a formal psychiatric diagnosis, with major depression being the most common at 17%. Cognitive impairment was also detected in about 23% of patients.25PubMed Central. Psychiatric morbidity in patients with transverse myelitis and stroke: A comparison Higher levels of distress tracked closely with greater physical disability.
Part of what makes myelitis psychologically brutal is its unpredictability. Many patients are previously healthy young adults who go from running errands to unable to walk within 48 hours. The uncertainty about how much function will return, layered on top of chronic pain and bladder problems, creates a fertile ground for anxiety and depression. Screening for mood disorders should be a routine part of follow-up care, yet it often is not, especially when the focus remains on the neurological deficits alone.
Conditions That Masquerade as Transverse Myelitis
Because the stakes of a missed diagnosis are high, neurologists maintain a deliberate list of conditions that can mimic inflammatory myelitis. Spinal cord infarction, as discussed above, is one. Others include compressive myelopathies from tumors, herniated discs, or epidural abscesses, all of which can cause progressive weakness and sensory loss. Neurosarcoidosis, spinal dural arteriovenous fistulas, and vitamin B12 deficiency myelopathy round out the main differential. Specific MRI features help separate these conditions. For instance, certain imaging characteristics like lesions near the junction of the brainstem and upper cord, bright spotty T2 lesions, and gadolinium enhancement favored a diagnosis of neuromyelitis optica-related myelitis over spinal cord infarction in a comparative study.26PubMed. Specific MRI findings help distinguish acute transverse myelitis of Neuromyelitis Optica from spinal cord infarction The broader point for patients is that if the initial workup does not add up, pushing for repeat imaging or additional tests is reasonable and sometimes essential.